When Are Genetic Tests Done During Pregnancy?
Learn when genetic tests like NIPT, carrier screening & amniocentesis are offered in US pregnancy. Understand timing & options to order a prenatal screening panel.
Genetic tests during pregnancy are performed at specific windows to screen for or diagnose chromosomal conditions and inherited disorders. In the United States, routine genetic screening typically begins between 9 and 12 weeks of gestation with non-invasive prenatal testing (NIPT), also called cell-free DNA screening. The exact timing depends on the type of test, your provider's protocol, and whether you choose a comprehensive prenatal screening panel. This guide explains when each major test is offered, what it checks, and how to order an all-in-one panel online in 2026.
First-Trimester Screening (Weeks 9–13)
The first trimester offers the earliest window for genetic screening. Two main approaches are available:
Non-Invasive Prenatal Testing (NIPT)
NIPT analyzes cell-free DNA (cfDNA) fragments circulating in the mother's blood. It is the most sensitive screening test for trisomy 21 (Down syndrome), trisomy 18, and trisomy 13, and can also detect sex chromosome aneuploidies. NIPT can be performed as early as 9 weeks, though some labs recommend waiting until 10 weeks to ensure a sufficient fetal fraction (the proportion of fetal cfDNA in the sample). Results typically return within 5–10 calendar days.
First-Trimester Combined Screening
This includes a blood test (measuring PAPP-A and free beta-hCG) plus a nuchal translucency ultrasound. It is done between 11 weeks 0 days and 13 weeks 6 days. The combined screen estimates the risk for Down syndrome and trisomy 18. It is often used alongside NIPT for integrated screening protocols.
Carrier Screening (Any Time, Preferably Early)
Carrier screening tests for recessive genetic conditions that a parent may carry without showing symptoms. In the US, the American College of Obstetricians and Gynecologists (ACOG) recommends offering carrier screening for cystic fibrosis, spinal muscular atrophy, and fragile X syndrome, as well as hemoglobinopathies based on ethnicity. Expanded panels can screen for dozens of disorders. This test can be done before pregnancy or during the first trimester. Many women choose to include carrier screening as part of a comprehensive prenatal screening panel ordered online.
- NIPT (cell-free DNA) – from 9 weeks
- Carrier screening – before pregnancy or first trimester
- First-trimester combined screen – 11–13 weeks
- Quad screen – 15–20 weeks
- Chorionic villus sampling (CVS) – 10–13 weeks (diagnostic)
- Amniocentesis – 15–20 weeks (diagnostic)
Second-Trimester Screening (Weeks 15–20)
Quad Screen (Maternal Serum Screening)
The quad screen measures four markers: alpha-fetoprotein (AFP), hCG, estriol, and inhibin A. It screens for open neural tube defects (such as spina bifida), Down syndrome, and trisomy 18. The test is performed between 15 and 20 weeks, with optimal timing at 16–18 weeks. For women who did not have first-trimester screening, the quad screen is often used alone. It can also be part of integrated screening that combines first- and second-trimester results.
Amniocentesis (Diagnostic)
Amniocentesis is the gold standard for diagnosing chromosomal abnormalities. A needle is guided by ultrasound to collect amniotic fluid containing fetal cells. It is typically offered when NIPT, first-trimester screening, or the quad screen indicates increased risk. The procedure carries a small risk of miscarriage (roughly 1 in 900 in experienced centers). Results for common trisomies are available in a few days; full karyotype may take 1–2 weeks.
When Is Integrated Screening Used?
Integrated screening combines results from first-trimester blood tests and ultrasound with second-trimester quad screen markers. This approach provides a single, highly accurate risk estimate. The first blood draw occurs at 11–13 weeks, and the second at 15–20 weeks. A genetic counselor may help interpret the final risk score.
Summary Table: Timing of Common Genetic Tests
| Test Type | Gestational Window | Purpose |
|---|---|---|
| NIPT (cell-free DNA) | From 9 weeks | Screen for trisomies 21, 18, 13; sex chromosome conditions |
| Carrier screening | Pre-pregnancy or first trimester | Identify recessive condition carriers (e.g., CF, SMA, fragile X) |
| First-trimester combined screen | 11–13 weeks | Screen for Down syndrome and trisomy 18 |
| Quad screen | 15–20 weeks | Screen for neural tube defects, Down syndrome, trisomy 18 |
| Chorionic villus sampling (CVS) | 10–13 weeks | Diagnose chromosomal conditions (diagnostic) |
| Amniocentesis | 15–20 weeks | Diagnose chromosomal conditions and neural tube defects (diagnostic) |
Choosing the Right Test for You
Your decision depends on your age, family history, and personal preference. A genetic counselor can help you weigh the benefits of early NIPT versus integrated screening, or whether diagnostic testing like CVS or amniocentesis is right for you. Many US expectant parents now opt for a comprehensive prenatal screening panel that combines NIPT, carrier screening, and early anatomy assessment in a single order.
You can order a prenatal screening panel online and receive your results quickly, often within 5–10 business days. All tests are reviewed by board-certified genetic counselors and are available to US residents without needing a prior clinic visit.
Ready to get screened? Order a prenatal carrier screening panel online through our partner and visit a local lab near you.
Order Prenatal Carrier ScreeningAbout PrenatalScreenings
PrenatalScreenings.com is a local lab information directory. We do not provide medical advice, diagnose conditions, or interpret test results. Always consult a qualified healthcare provider for personal medical guidance.